Stimulant treatment of adult attention-deficit/hyperactivity disorder

Psychiatric Clinics of North America

Volumn 27, Issue 2, 2004, Pages 361-372

  Spencer, Thomas ^a,b   Biederman, Joseph ^a,b   Wilens, Timothy ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE; PEMOLINE; PEMOLINE MAGNESIUM;

ATTENTION DEFICIT DISORDER; BECK DEPRESSION INVENTORY; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TOLERANCE; HAMILTON SCALE; HUMAN; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE;

ADULT; AMPHETAMINE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PEMOLINE;

EID: 1842477053     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2003.12.002     Document Type: Review

References (32)

1. Spencer T.J., Biederman J., Wilens T., Harding M., O'Donnell D., Griffin S. Pharmacotherapy of attention deficit hyperactivity disorder across the lifecycle: a literature review. J Am Acad Child Adolesc Psychiatry. 35:1996;409-432.
2. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD. [see comments] Arch Gen Psychiatry. 56:1999;1073-1086.
3. Wilens T., Pelham W., Stein M., Conners C.K., Abikoff H., Atkins M., et al. ADHD treatment with once daily oros methylphenidate: interim 12-month results from long-term open-label study. J Am Acad Child Adolesc Psychiatry. 42:2003;424-433.
4. Barkley R. Hyperactive girls and boys: stimulants drug effects on mother-child interactions. J Child Psychol Psychiatry. 30:1989;379-390.
5. Pelham W.E., Walker J.L., Sturges J., Hoza J. Comparative effects of methylphenidate on ADD girls and ADD boys. J Am Acad Child Adolesc Psychiatry. 28:1989;773-776.
6. Sharp W., Walter J., Marsh W., Ritchie G., Hamburger S., Castellanos X. ADHD in girls: clinical comparability of a research sample. J Am Acad Child Adolesc Psychiatry. 38:1999;40-47.
7. Brown R.T., Sexson S.B. A controlled trial of methylphenidate in black adolescents. Clin Pediatr (Phila). 27:1988;74-81.
8. Biederman J., Newcorn J., Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 148:1991;564-577.
9. Spencer T., Biederman J., Coffey B., Geller D., Faraone S., Wilens T. Tourette disorder and ADHD. Adv Neurol. 85:2001;57-77.
10. DuPaul G., Barkley R., McMurray M. Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad Child Adolesc Psychiatry. 33:1994;894-903.
11. Pliszka S.R. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry. 28:1989;882-887.
12. Taylor E., Schachar R., Thorley G., Wieselberg H.M., Everitt B., Rutter M. Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour. Psychol Med. 17:1987;121-143.
13. Voelker S.L., Lachar D., Gdowski L.L. The personality inventory for children and response to methylphenidate: preliminary evidence for predictive validity. J Pediatr Psychol. 8:1983;161-169.
14. Swanson J., Kinsbourne M., Roberts W., Zucker K. Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics. 61:1978;21-24.
15. Wood D.R., Reimherr F.W., Wender P.H., Johnson G.E. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry. 33:1976;1453-1460.
16. Mattes J.A., Boswell L., Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry. 41:1984;1059-1063.
17. Wender P.H., Reimherr F.W., Wood D.R., Ward M. A controlled study of methylphenidate in the treatment of attention-deficit disorder, residual type, in adults. Am J Psychiatry. 142:1985;547-552.
18. Gualtieri C.T., Ondrusek M.G., Finley C. Attention-deficit disorders in adults. Clin Neuropharmacol. 8:1985;343-356.
19. Bouffard R., Hechtman L., Minde K., Iaboni-Kassab F. The efficacy of two different dosages of methylphenidate in treating adults with attention-deficit/hyperactivity disorder. Can J Psychiatry. 48:2003;546-554.
20. Spencer T., Wilens T., Biederman J., Faraone S.V., Ablon J.S., Lapey K. A double-blind, cross-over comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 52:1995;434-443.
21. Paterson R., Douglas C., Hallmayer J., Hagan M., Krupenia Z. A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention-deficit/hyperactivity disorder. Aust N Z J Psychiatry. 33:1999;494-502.
22. Spencer T., Biederman J., Wilens T., et al. Efficacy of a Mixed Amphetamine Salts Compound in Adults With Attention-Deficit/Hyperactivity Disorder. Arch Gen Psychiatry. 58:2001;775-782.
23. National Institute of Mental Health. CGI. (Clinical Global Impression Scale)-NIMH. Psychopharmacol Bull. 21:1985;839-844.
24. DuPaul G., Power T., Anastopoulos A., Reid R. ADHD rating scale IV: checklists, norms, and clinical interpretation. 1998;Guilford Press, New York.
25. Barkley R.A. Attention-deficit/hyperactivity disorder: a handbook for diagnosis and treatment. 1990;Guilford Press, New York.
26. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
27. Beck A.T., Ward C.E., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 4:1961;561-571.
28. Hamilton M. The measurement of anxiety states by rating. Br J Med Psychol. 32:1959;50-55.
29. Spencer T., Biederman J., Wilens T., Doyle R., Johnson M. Efficacy of methylphenidate in adults with ADHD. Findling R. Scientific Proceedings of the Annual Meeting: American Academy of Child and Adolescent Psychiatry. 2002;32 American Academy of Child and Adolescent Psychiatry, San Francisco.
30. Wender P.H., Reimherr F.W., Wood D.R. Attention-deficit disorder (minimal brain dysfunction) in adults: a replication study of diagnosis and drug treatment. Arch Gen Psychiatry. 38:1981;449-456.
31. Wilens T.E., Biederman J., Spencer T.J., Frazier J., Prince J., Bostic J., et al. Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 19:1999;257-264.
32. Weisler R, Chrisman AK, Wilens T. Adderall XR dosed once daily in adult patients with ADHD. Presented at the Annual Meeting of the American Psychiatric Association. San Francisco, October 20, 2003.